FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
PMA Final Decisions Rendered for June 2004 |
Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities. If you cannot access the documents you are interested in, please use the accessibility link for assistance. Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis.
A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available. Information about the PDF Reader is available.
PMA Original Approvals
6/7/04 |
Euclid Systems Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear |
Euclid Systems Corporation Herndon, VA 20171 |
Approval for the Euclid Systems Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear. The lenses are indicated for use in the reduction of myopic refractive error in non-diseased eyes. The lenses are indicated for overnight wear for the temporary reduction of myopia up to 5.00 diopters with eyes having astigmatism up to 1.50 diopters. The lenses may only be disinfected using a chemical disinfection system. Note: To maintain the Orthokeratology effect of myopia reduction, overnight lens wear must be continued on a prescribed schedule. Failure to do so can affect daily activities (e.g., night driving), visual fluctuations and changes in intended correction. |
6/17/04 |
Stelid II Steroid eluting pacing leads, Models BTF25D, BTF26D, BJF24D, BJF25D, UTF25D, and UTF26D, Stelix steroid eluting pacing leads models BR45D and BR46D, Stelix II steroid eluting pacing leads model BRF25D and BRF26D |
ELA Medical, Inc. Plymouth, MN 55441 |
Approval for the Stelid II, Stelix, and Stelix II Endocardial Pacing Leads. The Stelid II, Stelix, and Stelix II endocardial steroid eluting pacing leads are designed to be used with an implantable pacemaker for pacing and sensing of the heart. The Stelid II models BTF25D/26D and UTF25D/26D are intended for permanent pacing and sensing of the ventricle. The Stelid II models BJF24D/25D, Stelix models BR45D/46D, and Stelix II models BRF25D/26D are intended for permanent pacing and sensing of the atrium. |
6/8/04 |
IntraStent® DoubleStrut™ Stent |
ev3, Inc. Plymouth, MN 55442 |
Approval for the IntraStent DoubleStrut Stent. The device is indicated for improving luminal diameter in patients with symptomatic atherosclerotic disease of the common and/or external iliac arteries up to 100 mm in length, with a reference vessel diameter of 5 to 10 mm. |
6/30/04 |
St. Jude Medical® Epic™ HF System |
St. Jude Medical, Inc. Sunnyvale, CA 94086 |
Approval for the St. Jude Medical Epic™ HF System and the St. Jude Medical® Atlas® + HF System. These systems are indicated for the following: The St. Jude Medical Epic HF and Atlas + HF Systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The Epic HF and Atlas + HF Systems are also intended to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section), and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration. |
PMA Supplemental Approvals
P790017/S081 6/23/04 Real-Time |
Sprinter Over-The-Wire (OTW) Balloon Dilatation Catheter (multiple model numbers for the 1.5 mm to 4.0 mm diameters) |
Medtronic Vascular, Inc. Santa Rosa, CA 95403 |
Approval for minor design, packaging and labeling changes to the Stormer OTW Ballon Dilatation Catheter including the addition of 6 mm and 12 mm balloon lengths. The device, as modified, will be marketed under the trade name Sprinter OTW Balloon Dilatation Catheter and is indicated as follows: For balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion. The Sprinter OTW Balloon Dilatation Catheter (balloon models 2.5 mm – 4.0 mm) is also indicated for post-delivery expansion of balloon expandable stents. Note: Bench testing was conducted with the Sprinter OTW Balloon Dilatation Catheter and marketed balloon expandable stents. Consideration should be taken when this device is used with different manufacturers’ stents due to differences in stent design. |
P790019/S018 6/16/04 Special |
Device: Abbott AxSYM® HAVAB®-M Assay |
Abbott Laboratores Abbott Park, IL 60064 |
Approval for changes in the manufacturing process. |
P810046/S216 6/18/04 180-Day |
VOYAGER™ RX Coronary Dilatation Catheter |
Guidant Corporation Temecula, CA 92591 |
Approval for the VOYAGER™ RX Coronary Dilatation Catheter. The device, as modified, is indicated for 1) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion, 2) balloon dilatation of a coronary occlusion for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction, and 3) balloon dilatation of stent after implantation (Testing including the following Guidant stents: MULTI-LINK: PIXEL® and PENTA® and ZETA® Coronary Stent Systems). |
P830061/S037 6/8/04 135-Day |
Lead Models 4074, 4092, 4574, 4592 |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval to market these lead models manufactured using MED 2000 silicone adhesive. |
P840001/S073 6/16/04 Real-Time |
Itrel 3, Synergy and Synergy Vertitel Spinal Cord Stimulators |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for a new permanently implanted surgical lead (Model 3999 Hinged 2 x 4 Lead) to be used with Medtronics fully implantable neurostimulation systems for Spinal Cord Stimulation (P840001) or the external radio frequency neurostimulation systems for Spinal Cord Stimulation (K934065). |
P840039/S053 6/14/04 Real-Time |
Silicone and PMMA Intraocular Lenses and Ocucoat |
Bausch & Lomb San Dimas, CA 91773 |
Approval for the use of a 100% Ethylene Oxide sterilization method in products in their final packaged form. Sterilization will occur at CosMed, Inc., Located in South Plainfield New Jersey. The products affected by this change are the PMMA and silicone lenses and Ocucoat Viscoadherent manufactured at Bausch & Lomb, Inc., Clearwater, Florida. |
P850089/S053 6/8/04 135-Day |
Lead Models 5092, 5592, 5554, 5594 |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval to market these lead models manufactured using MED 2000 silicone adhesive. |
P860004/S061 6/4/04 Special |
Synchromed Implantable Infusion System |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for a change to the Medtronic Model 8840 N’Vision Programmer Technical Manual to add a precaution to identify an environment in which the device is not certified for use. |
P860047/S016 6/14/04 Real-Time |
Silicone and PMMA Intraocular Lenses and Ocucoat |
Bausch & Lomb San Dimas, CA 91773 |
Approval for the use of a 100% Ethylene Oxide sterilization method in products in their final packaged form. Sterilization will occur at CosMed, Inc., Located in South Plainfield New Jersey. The products affected by this change are the PMMA and silicone lenses and Ocucoat Viscoadherent manufactured at Bausch & Lomb, Inc., Clearwater, Florida. |
P880090/S020 6/14/04 Real-Time |
Silicone and PMMA Intraocular Lenses and Ocucoat |
Bausch & Lomb San Dimas, CA 91773 |
Approval for the use of a 100% Ethylene Oxide sterilization method in products in their final packaged form. Sterilization will occur at CosMed, Inc., Located in South Plainfield New Jersey. The products affected by this change are the PMMA and silicone lenses and Ocucoat Viscoadherent manufactured at Bausch & Lomb, Inc., Clearwater, Florida. |
P900023/S040 6/28/04 Real-Time |
ABIOMED® BVS5000 Bi-Ventricular Support System and AB5000™ Circulatory Support System |
ABIOMED, Inc. Danvers, MA 01923 |
Approval for the addition of two inflow cannulae (malleable 42 Fr. And 32 Fr.) to be added to the currently approved cannulae used with the BVS5000 Bi-Ventricular Support System and the AB5000™ Circulatory Support System. |
P900023/S041 6/28/04 Real-Time |
ABIOMED® BVS5000 Bi-Ventricular Support System and AB5000™ Circulatory Support System |
ABIOMED, Inc. Danvers, MA 01923 |
Approval for the addition of the Sewing Cuff for cannula placement for the use with the BVS5000 Bi-Ventricular Support System and the AB5000™ Circulatory Support System. |
P900039/S013 6/7/04 180-Day |
NeuGraft Collagen/ Hydroxyapatite Bone Graft Substitute |
NEUCOLL, Inc. Los Gatos, CA 95032 |
Approval for the addition of the product “NeuGraft®”. Collagraft® Strip Bone Graft Matrix (Collagraft) was originally approved by the FDA on January 27, 1994 (review of P900039). The product currently continues to be marketed by that name. NeuGraft® is identical to Collagraft® Strip bone Graft Matrix, except that the brand name on the labeling is different. The labeling for NeuGraft® indicated and explains that the two products are the same, but are sold through different distribution channels. As proposed, the product will continue to be sold using both names Collagraft® and NeuGraft®. There will be no change affecting safety and effectiveness for this product. |
P910061/S011 6/14/04 Real-Time |
Silicone and PMMA Intraocular Lenses and Ocucoat |
Bausch & Lomb San Dimas, Ca 91773 |
Approval for the use of a 100% Ethylene Oxide sterilization method in products in their final packaged form. Sterilization will occur at CosMed, Inc., Located in South Plainfield New Jersey. The products affected by this change are the PMMA and silicone lenses and Ocucoat Viscoadherent manufactured at Bausch & Lomb, Inc., Clearwater, Florida. |
P920014/S019 6/29/04 180-Day |
HeartMate XVE LVAS |
Thoratec Corporation Pleasanton, CA 94588 |
Approval of the post approval study for the device. |
P920015/S029 6/8/04 180-Day |
Model 6949 and 6931 Leads |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the addition of a polyurethane overlay. |
P920015/S030 6/8/04 180-Day |
Model 6948 and 6930 Leads |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the addition of a polyurethane overlay. |
P930016/S018 6/7/04 180-Day |
STAR S4 ActiveTrak™ Excimer Laser System and WaveScan WaveFront® System |
VISX, Inc. Santa Clara, CA 95051 |
Approval for Software upgrade: WaveScan Software Version 3.5 changes from currently approved Version 3.07 (under P930016/S016) for VISX STAR S4 ActiveTrak™ Excimer Laser System for wavefront-guided LASIK treatments of myopic astigmatism up to -6.00 D MRSE, with cylinder between 0.00 and -3.00 D. |
P930039/S019 6/8/04 135-Day |
Lead Models 4068, 4568, 5068, 5568 |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval to market these lead models manufactured using MED 2000 silicone adhesive. |
P950014/S022 6/10/04 Real-Time |
Prostatron™ Praktis |
Urologix, Inc. Minneapolis, MN 55447 |
Approval for design changes to include changing the contacts on the internal wiring from tin to gold and a modification to the software to include an additional alarm. The device, as modified, will be marketed under the trade name Prostatron™ Praktis and is indicated for the treatment of benign prostatic hyperplasia (BPH). |
P950032/S038 6/14/04 Real-Time |
Apligraf |
Organogenesis, Inc. Canton, MA 02021 |
Approval to introduce a new cell strain into the production of Apligraf (i.e., HDF B700) and a modification of the methods for detecting Cytomegalovirus (CMV). |
P960007/S017 6/28/04 180-Day |
Transcyte |
Smith & Nephew Wound Management La Jolla, CA 92037 |
Approval for the termination of the post-approval study protocol entitle: “A randomized, controlled within-patient-paired study to compare the effectiveness of TransCyte and Biobrane in the treatment of mid-dermal to indeterminate depth burn wounds.” |
P970004/S025 6/8/04 180-Day |
Medtronic® InterStim® Sacral Nerve Stimulation System |
Medtronic Gastroenterology/ Urology (MGU) Shoreview, MN 55126 |
Approval of the post-approval study for the device. |
D970012/S011 6/7/04 180-Day |
AMS 700 Series Product Line Inflatable Penile Prostheses |
American Medical Systems, Inc. Minnetonka, MN 55343 |
Approval for removal of the disclaimer related to the trade name “InhibiZone” (i.e., “Zones of inhibition shown in laboratory data and have not been verified in clinical studies.”) and related changes to the labeling. |
D970012/S023 6/7/04 Special |
AMS 700 Series Product Line Inflatable Penile Prostheses with InhibiZone™ Antibiotic Surface Treatment |
American Medical Systems, Inc. Minnetonka, MN 55343 |
Approval for labeling modifications cautioning against the concomitant use of injection therapy for erectile dysfunction. |
P970027/S001 6/30/04 Special |
Abbott AxSYM® Anti-HCV |
Abbott Laboratories Abbott Park, IL 60064 |
Approval for changes in the manufacturing process. |
6/29/04 Panel |
LADARVision® 4000 Excimer Laser System |
Alcon Laboratories, Inc. Orlando, FL 32826 |
Approval for the LADARVision® 4000 Excimer Laser System. The device uses a 6.5 mm optical zone, a 9.00 mm ablation zone, is locked-out for treatments above -9.75 diopters (d) sphere, -5.00D cylinder, and -10.63D spherical equivalent (SE), and is indicated for wavefront-guided laser assisted in-situ keratomileusis (LASIK): 1) for the reduction or elimination of myopic astigmatism up to -8.00D sphere with -0.50 to -4.00D cylinder and up to -8.00D SE at the spectacle plane; 2) in patients who are 21 years of age or older; and 3) in patients with documented stability of refraction for the prior 12 months, as demonstrated by a change in sphere and cylinder of less than or equal to 0.50D for a SE of up to -6.00 D and less than or equal to 0.75D for a SE greater than -6.00D. |
D980003/S004 6/25/04 Real-Time |
Keramos™ Ceramic/ Ceramic Hip |
Encore Medical, L.P. Austin, TX 78758 |
Approval for removal of the rim from the Keramos™ acetabular shell. |
P980016/S041 6/25/04 180-Day |
Medtronic® Intrinsic 30 Model 7287 Dual Chamber Implantable Cardioverter Defibrillator (ICD) System with Model 9996 Application Software and Medtronic™ Intrinsic Model 7288 Dual Chamber Implantable Cardioverter Defibrillator (ICD) System with Model 9997 Application Software |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic® Intrinsic 30 Model 7287 Dual Chamber Implantable Cardioverter Defibrillator (ICD) System with Model 9996 Application Software and Medtronic™ Intrinsic Model 7288 Dual Chamber Implantable Cardioverter Defibrillator (ICD) System with Model 9997 Application Software, which are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. |
P980035/S037 6/7/04 180-Day |
Medtronic AT500 DDDRP Pacing System |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for changes to the investigational plan for the Medtronic’s AT500 DDDRP Pacing System’s Post-Approval Study. |
P980037/S009 6/22/04 Real-Time |
AngioJet® Rheolytic™ Thrombectomy System |
Possis Medical, Inc. Minneapolis, MN 55433 |
Approval for changes to the Pump Set (also called the Pump Set Plus) which included: 1) modification to the pump outlet and inlet fittings; 2) changes to the depth of the check ball seat and elimination of the check ball spring; 3) changes to the prime sensor cup; 4) changes to the piston head; 5) color changes to the luer; and 6) changes to the paratubing assembly. |
P980037/S010 6/22/04 Real-Time |
AngioJet® Rheolytic™ Thrombectomy System |
Possis Medical, Inc. Minneapolis, MN 55433 |
Approval for changes to the packaging specifically to the inner tray and outer pouch. |
P980037/S011 6/30/04 Special |
AngioJet® Rheolytic™ Thrombectomy System |
Possis Medical, Inc. Minneapolis, MN 55433 |
Approval for the addition of a boxed warning regarding use in pulmonary vasculature to all Possis AngioJet Catheter Instruction for Use documents. |
P990004/S006 6/28/04 Real-Time |
Surgifoam Absorbable Gelatin Sponge |
Ethicon, Inc. Somerville, NJ 08876 |
Approval for revision on the labeling to include the use of the product with thrombin. |
P990013/S004 6/23/04 Special |
Staar Surgical UV-Absorbing Collamer Foldable Intraocular Lenses |
Staar Surgical Company Monrovia, CA 91016 |
Approval to modify the package insert. |
P990026/S022 6/22/04 Real-Time |
GlucoWatch G2 Biographer |
Cygnus, Inc. Redwood City, CA 94063 |
Approval for multiple-patient use of the GlucoWatch G2 Biographer. |
P990066/S017 6/7/04 180-Day |
Senographe 2100D Full Field Digital Mammography System |
GE Medical Systems Milwaukee, WI 53188 |
Approval for a name change for the Senographe 2100D FFDM System to the Senographe DS FFDM System. |
P000009/S012 6/22/04 Real-Time |
The Belos, Tachos ATx, and Lexos Implantable Cardioverter Defibrillator Families and Cardiac Airbag |
BIOTRONIK, Inc. Lake Oswego, OR 97035 |
Approval for changes to the current FDA-approved labeling for BIOTRONIK Implantable Cardioverter Defibrillators. |
P000018/S040 6/10/04 180-Day |
Novoste™ Beta-Cath™ 3.5F System |
Novoste Corp. Norcross, GA 30093 |
Approval for the Beta-Rail 3.5F Delivery Catheter with distal improvements, and a change in the Procedure Accessory Pack. |
P000028/S005 6/18/04 Special |
AFFINITY™ Anterior Cervical Cage System |
Medtronic Sofamor Danek Memphis, TN 38132 |
Approval for an alternative surgical technique in which the reaming step is removed from the surgical procedure. |
P000054/S001 6/10/04 Real-Time |
INFUSE™ Bone Graft |
Medtronic Sofamor Danek Memphis, TN 38132 |
Approval for 1) an increase in the expiration date of the 4.2 and 12 mg vialed rhBMP-2 component of the referenced devices from 36 to 48 months; 2) an increase in the expiration date of the commercial kit component from 24 to 36 months; and 3) the protocol to be followed for all future expiration date changes. |
P000058/S010 6/10/04 Real-Time |
INFUSE™ Bone Graft/LT-Cage Lumbar Tapered Fusion Device |
Medtronic Sofamor Danek Memphis, TN 38132 |
Approval for 1) an increase in the expiration date of the 4.2 and 12 mg vialed rhBMP-2 component of the referenced devices from 36 to 48 months; 2) an increase in the expiration date of the commercial kit component from 24 to 36 months; and 3) the protocol to be followed for all future expiration date changes. |
P010031/S013 6/23/04 Real-Time |
Model 7303 InSync Maximo Dual Chamber ICD system and Model 9998 Application Software Version 1.0 for the Model 2090 Programmer system |
Medtronic, Inc. Minneapolis, MN 55432 |
Model 7303 InSync Maximo Dual Chamber ICD system and Model 9998 Application Software Version 1.0 for the Model 2090 Programmer system. |
P010031/S014 6/24/04 180-Day |
Medtronic® InSync II Protect Model 7295 Implantable Cardioverter Defibrillator (ICD) System |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for a manufacturing site located at Medtronic Puerto Rico Operations Company (MPROC), Juncos, Puerto Rico. |
P020004/S006 6/2/04 180-Day |
Gore EXCLUDER™ Bifurcated Endoprosthesis |
W.L. Gore & Associated, Inc. Flagstaff, AZ 86001 |
Approval for a low permeability version of the Gore EXCLUDER Bifurcated Endoprosthesis. |
P020014/S005 6/10/04 180-Day |
Essure™ System |
Conceptus, Inc. San Carlos, CA 94070 |
Approval for the device labeling to include 3-year effectiveness results and other labeling changes. |
P020025/S004 6/9/04 180-Day |
EPT-1000 XP Cardiac Ablation System |
EP Technologies, Inc. San Jose, CA 95134 |
Approval for a change in design of the EPT-1000 XP Cardiac Ablation Controller. The change in design incorporates the originally approved EPT-1000 XP Controller with Track While Ablate (TWA) technology to visualize catheter navigation during RF energy delivery using the Real Time Position Management (RPM) system. The device, as modified, will be marketed under the trade name Track While Ablate (TWA) EPT-1000 XP Cardiac Ablation System. The TWA EPT-1000 XP Cardiac Ablation Controller and Accessories are indicated for use in conjunction with standard and high power catheters for cardiac ablation procedures. |
P020026/S008 6/14/04 Real-Time |
CYPHER™ Sirolimus-Eluting Coronary Stent on the RAPTOR™ Over-the-Wire Delivery System or RAPTORRAIL® Rapid Exchange Delivery System |
Cordis Corporation Miami Lakes, FL 33102 |
Approval for a modification to the residual solvent test method for the Cypher™ Sirolimus-eluting Coronary Stent. |
P020045/S005 6/10/04 Real-Time |
7F Freezor® Cardiac CryoAblation Catheter and CCT.2 CryoConsole System |
CryoCath Technologies, Inc. Quebec, Canada H9H 5H3 |
Approval for modifications to the Freezor® and Freezor® Xtra cryoablation systems. |
P020050/S001 6/4/04 180-Day |
WaveLight ALLEGRETTO WAVE™ Excimer Laser System |
WaveLight Laser Technologie AG Earlangen, Germany 91058 |
Approval for a manufacturing site located at WaveLight Laser Technologie AG, Pressath, Germany. |
P030005/S002 6/28/04 Special |
CONTAK RENEWAL TR (model H120 and H125) |
Guidant Corporation Cardiac Rhythm Management St. Paul, MN 55112 |
Approval for minor labeling changes to the CRT-P device. |
P030008/S001 6/4/04 180-Day |
WaveLight ALLEGRETTO WAVE™ Excimer Laser System |
WaveLight Laser Technologie AG Earlangen, Germany 91058 |
Approval for a manufacturing site located at WaveLight Laser Technologie AG, Pressath, Germany. |
30-Day Notices (135 Day Supplement was not required)
P810025/S023 6/4/04 |
Amvisc TM and Amvisc TM Plus |
Bausch and Lomb San Dimas, CA 91773 |
Addition of a new quality control test method for the Amvisc TM and the Amvisc TM Plus. |
P860019/S200 6/10/04 |
Maverick Monorail PTCA Catheter System and Maverick2 Monorail PTCA Catheter System |
Boston Scientific Maple Grove, MN 55311 |
Change in the manufacturing process to propose alternative parameters for laser welding of the port bond on the Maverick™ Monorail and Maverick™2 Monorail PTCA Catheter Systems. |
P900056/S081 6/18/04 |
Rotablator Rotational Angioplasty System |
Boston Scientific Corporation Maple Grove, MN 55311 |
Reduction in test frequency for in-process, destructive package testing. |
P940040/S004 6/23/04 |
AMPLICOR® Mycobacterium tuberculosis (MTB) Test |
Roche Molecular Systems, Inc. Pleasanton, CA 94588 |
Change in process points at which chemical and functional testing are performed. |
P000046/S009 6/4/04 |
Staarvisc II, Shellgell, and CoEase |
Anika Therapeutics, Inc. Woburn, MA 01801 |
Addition of a Quality Test Method for Staarvisc II, Shellgel and CoEase. |
P000052/S025 6/10/04 |
GALILEO Intravascular Radiotherapy Systems |
Guidant Corporation Houston, TX 77054 |
Discontinue the preventative maintenance program on the head and base components of the GALILEO Source Delivery Unit (SDU). |
P030017/S001 6/28/04 |
Precision™ Spinal Cord Stimulator System |
Advanced Bionics Corporation Sylmar, CA 91342 |
Addition of a larger sterilization chamber. |
P030019/S004 6/4/04 |
Orthovisc® High Molecular Weight Hyaluranon |
Anika Therapeutics, Inc. Woburn, MA 01801 |
Addition of a new quality control test. |
P030026/S001 6/14/04 |
VITROS Immunodiagnostic Products Anti-HBc IgM Reagent Pack and Calibrator |
Ortho-Clinical Diagnostics Rochester, NY 14626 |
Change in the manufacturing equipment and manufacturing process steps acceptance criteria associated with this equipment change. |
Summary of PMA Originals & Supplements Approved
Originals: 4
Supplements: 49
Summary of PMA Originals Under Review
Total Under Review: 89
Total Active: 41
Total On Hold: 48
Number Greater Than 180 Days: 3
Summary of PMA Supplements Under Review
Total Under Review: 200
Total Active: 112
Total On Hold: 88
Number Greater Than 180 Days: 3
Summary of All PMA Submissions Received
Originals: 5
Supplements: 49
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 49
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 107.4
FDA Time: 92.8 Days MFR Time: 14.6 Days
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH